Mineralys Therapeutics (NASDAQ:MLYS) Sees Strong Trading Volume on Analyst Upgrade
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) saw strong trading volume on Wednesday after HC Wainwright raised their price target on the stock from $30.00 to $42.00. HC Wainwright currently has a buy rating on the stock. 303,503 shares were traded during trading, a decline of 17% from the previous session’s volume of 367,553 […]
